Amrubicin
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Also known as: amrubicin HCl, amrubicin hydrochloride, SM-5887
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Amrubicin is a drug catalogued in DrugCentral.
- ATC code: L01DB10 (Anthracyclines and related substances).
- Molecular formula: C25H25NO9; molecular weight 483.47 g/mol.
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
L01DB10 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES › Anthracyclines and related substances |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Disease recurrence | 119.2 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Amrubicin is on its molecule page.
| Molecular formula | C25H25NO9 |
|---|---|
| Molecular weight | 483.47 g/mol |
| CAS number | 110267-81-7 |
| InChIKey | VJZITPJGSQKZMX-XDPRQOKASA-N |
| PubChem CID | 3035016 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is the chemical formula of Amrubicin?
Amrubicin has the molecular formula C25H25NO9 and a molecular weight of 483.47 g/mol.
Browse: all drugs starting with A · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 202 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1186894 — compound record and bioactivity
- PubChem CID 3035016 — chemical identifiers
- DrugBank DB06263 — drug record
- FDA UNII 93N13LB4Z2 — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.